Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT04133714
Other study ID # 2019-313
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date November 1, 2020
Est. completion date December 2023

Study information

Verified date October 2019
Source Second Affiliated Hospital, School of Medicine, Zhejiang University
Contact Hongjie Jiang, Dr.
Phone +86 13777830137
Email insjhj@zju.edu.cn
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This clinical RCT study intends to combined different forms of multi-channel tDCS with the routine cognitive training process to treat patients with post-stroke cognitive dysfunction. The therapeutic effects among single-channel tDCS group, multi-channel tDCS and pseudo-multichannel tDCS group will be compared. Brain magnetic resonance mechanism research will also be included to reveal the possible mechanism of multi-channel tDCS technology for PSCI brain network. Thus, the efficacy and mechanism of multi-channel tDCS in post-stroke cognitive function rehabilitation will be researched both in the clinical and basic levels.


Recruitment information / eligibility

Status Recruiting
Enrollment 180
Est. completion date December 2023
Est. primary completion date March 2023
Accepts healthy volunteers No
Gender All
Age group 18 Years to 60 Years
Eligibility Inclusion Criteria: - 18-60 year-old - diagnosed cerebral apoplexy, meeting the diagnostic criteria of ICD-10 - cognitive function, perceptual function decline after stroke - first onset and duration of 3-12 months - right-handed - MMSE =25 - MoCA =25 - sign informed consent voluntarily and comply with the study plan Exclusion Criteria: - NIHSS =21 points - MoCA =18, or DRS-2 = 124, or CES-D = 16 - taking drugs that affect central nervous activity, such as nerve antagonists - specific contraindication, such as electrode patch allergy, local skin injury or - - - - inflammation, and hyperalgesia in stimulated areas - patients use implantable electronic devices (such as cardiac pacemakers) or have - metal implants such as stents that affect MRI examination - patients with a previous history of epilepsy, mental illness or skull injury - patients with dementia or obvious cognitive dysfunction before stroke - patients with aphasia or dysarthria and cannot complete the scale evaluation - pregnancy

Study Design


Related Conditions & MeSH terms


Intervention

Device:
multi-channel tDCS
multi-channel transcranial direct current stimulation, tDCS
single-channel tDCS
single-channel transcranial direct current stimulation

Locations

Country Name City State
China Southwest Hospital Chongqing
China Rainbowfish Rehabilitation Nursing Care Hangzhou Zhejiang
China SAHZhejiangU Hangzhou Zhejiang
China Zhejiang Provincial People's Hospital Hangzhou Zhejiang

Sponsors (1)

Lead Sponsor Collaborator
Second Affiliated Hospital, School of Medicine, Zhejiang University

Country where clinical trial is conducted

China, 

Outcome

Type Measure Description Time frame Safety issue
Primary MMSE Mini-mental State Examination Change from Baseline MMSE at 2 weeks and 3 months after intervention
Primary MoCA Montreal Cognitive Assessment Change from Baseline MoCA at 2 weeks and 3 months after intervention
Primary AVLT The Auditory-Verbal Learning Test Change from Baseline AVLT at 2 weeks and 3 months after intervention
Primary WAIS-DST WAIS Digit Symbol Test Change from Baseline WAIS-DST at 2 weeks and 3 months after intervention
Secondary DEX Dysexecutive Ques-tionnaire Change from Baseline DEX at 2 weeks and 3 months after intervention
Secondary GNAT Go/No-go Association Task Change from Baseline GNAT at 2 weeks and 3 months after intervention
See also
  Status Clinical Trial Phase
Recruiting NCT05273125 - MOBility Disorders Assessment in Patients With Mild COGnitive Disorders
Active, not recruiting NCT04049695 - Improving Cognition After Cancer N/A
Completed NCT05912374 - Adapting a Behavioral Intervention to Accommodate Cognitive Dysfunction in People Who Inject Drugs N/A
Recruiting NCT03977350 - Association Between qEEG Measure and Post-Operative Cognitive Dysfunction (POCD) and Postoperative Delirium (POD)
Not yet recruiting NCT06027632 - Remotely Supervised Computerized Cognitive Stimulation to Reduce Post-chemotherapy Cognitive Difficulties in Patients Treated for Localized Breast Cancer N/A
Terminated NCT00754013 - Evaluating The Efficacy And Safety Of Donepezil Hydrochloride (Aricept) In The Treatment Of The Cognitive Dysfunction Exhibited By Children With Down Syndrome, Aged 6 To 10 Phase 3
Terminated NCT00754052 - Evaluating The Efficacy And Safety Of Donepezil Hydrochloride (Aricept) In The Treatment Of The Cognitive Dysfunction Exhibited By Children With Down Syndrome, Aged 11 To 17 Phase 3
Completed NCT00719628 - Depth of Anaesthesia and Cognitive Dysfunction N/A
Recruiting NCT05014399 - Cognitive Impairment in Colorectal Cancer Patients Receiving Cytotoxic Chemotherapy
Completed NCT04966455 - Effect of Raisins on Cognitive Function in Healthy Older Adults Phase 3
Recruiting NCT05372159 - Vanderbilt Memory and Aging Project
Completed NCT03243279 - BRS and Outcomes in Cardiothoracic Surgery
Completed NCT04093882 - The Relevance of the Blood-brain Barrier to Cognitive Dysfunction and Alzheimer's Disease
Recruiting NCT05732285 - A Pilot Randomized Controlled Trial: CoINTEGRATE N/A
Completed NCT06059768 - Urdu Translation and Psychometric Analysis of Lawton IADLS.
Completed NCT04562662 - Evaluation of mediVR-KAGURA Guided Therapy N/A
Completed NCT04624529 - Validity and Reliability of a Self-evaluation Tool for Cognitive Deficits in the Acute Stage After Stroke
Not yet recruiting NCT04079075 - Multiple Interventions to Prevent Cognitive Decline N/A
Active, not recruiting NCT04638101 - Building the Path to Resilience in Preterm Infants: Mindfulness-based Intervention N/A
Active, not recruiting NCT04556305 - Lifestyle Physical Activity and Cognitive Training Interventions N/A